volume 47 issue 27 pages 12902-12913

Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design

Publication typeJournal Article
Publication date2023-06-26
scimago Q2
wos Q3
SJR0.493
CiteScore5.0
Impact factor2.5
ISSN11440546, 13699261
Materials Chemistry
General Chemistry
Catalysis
Abstract
The biomolecular interactions of two previously reported cycloplatinated complexes, [Pt(C^N)(SMe2)(OCOCF3)] (C^N = deprotonated benzo[h]quinoline (bhq), 1, or deprotonated 2-phenylpyridine (ppy), 2), with bovine serum albumin (BSA) were investigated using various spectroscopic techniques. Structural characterization of 1 and 2 by NMR, UV-vis spectroscopies and conductivity measurements in aqueous media revealed that the TFAc functions as a leaving group ligand and is rapidly replaced by water molecules to form cationic cycloplatinated complexes having an aqua ligand, [Pt(C^N)(SMe2)(H2O)]+[CF3COO]−. Fluorescence titration of BSA indicated a strong binding interaction between Pt(II) compounds and protein with a static quenching mechanism. The thermodynamic parameters (ΔH°, ΔG° and ΔS°) showed that the binding was exothermic, involving main noncovalent hydrophobic forces and ionic interactions. As revealed by the displacement experiment, while 1 could bind to subdomain IIIA (site II) of albumin, the binding sites of 2 were mostly located at subdomain IIA (site I). The synchronous fluorescence spectra indicate that the cycloplatinated compounds induce structural changes in the protein structure. Moreover, far-UV CD spectroscopy is in agreement with a reduction of the α-helix content of albumin through binding. Further evidence for noncovalent association was obtained from inductively coupled plasma-optical emission spectroscopy (ICP-OES). In addition, the cytotoxicity investigation of 1 as a model complex against two human leukemic cancer cell lines (K562 and HL-60), MCF-7 (human breast adenocarcinoma), U-87MG (human glioblastoma cell line) and HT-29 (human colorectal adenocarcinoma cell line) suggested that 1 is more cytotoxic than cisplatin against HL-60 and generally toxic toward K562, MCF-7 and U-87MG. Finally, the quantitative structure–activity relationship (QSAR) was applied to correlate the structure of some cycloplatinated complexes including 1 and 2 with the SA albumin binding constant.
Found 
Found 

Top-30

Journals

1
International Journal of Biological Macromolecules
1 publication, 33.33%
Microchemical Journal
1 publication, 33.33%
Russian Chemical Reviews
1 publication, 33.33%
1

Publishers

1
2
Elsevier
2 publications, 66.67%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 33.33%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
3
Share
Cite this
GOST |
Cite this
GOST Copy
Aseman M. et al. Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design // New Journal of Chemistry. 2023. Vol. 47. No. 27. pp. 12902-12913.
GOST all authors (up to 50) Copy
Aseman M., Negaresh P., Shojaeifard Z., Hemmateenejad B., Ali Nabavizadeh S. Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design // New Journal of Chemistry. 2023. Vol. 47. No. 27. pp. 12902-12913.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1039/d3nj00867c
UR - https://xlink.rsc.org/?DOI=D3NJ00867C
TI - Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design
T2 - New Journal of Chemistry
AU - Aseman, Marzieh
AU - Negaresh, Parisa
AU - Shojaeifard, Zahra
AU - Hemmateenejad, Bahram
AU - Ali Nabavizadeh, S.
PY - 2023
DA - 2023/06/26
PB - Royal Society of Chemistry (RSC)
SP - 12902-12913
IS - 27
VL - 47
SN - 1144-0546
SN - 1369-9261
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Aseman,
author = {Marzieh Aseman and Parisa Negaresh and Zahra Shojaeifard and Bahram Hemmateenejad and S. Ali Nabavizadeh},
title = {Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design},
journal = {New Journal of Chemistry},
year = {2023},
volume = {47},
publisher = {Royal Society of Chemistry (RSC)},
month = {jun},
url = {https://xlink.rsc.org/?DOI=D3NJ00867C},
number = {27},
pages = {12902--12913},
doi = {10.1039/d3nj00867c}
}
MLA
Cite this
MLA Copy
Aseman, Marzieh, et al. “Noncovalent interactions of antitumor cycloplatinated complexes containing trifluoroacetate ligands as the leaving group with bovine serum albumin. Implications for drug design.” New Journal of Chemistry, vol. 47, no. 27, Jun. 2023, pp. 12902-12913. https://xlink.rsc.org/?DOI=D3NJ00867C.